Nick Keher


Nick joined Benevolent AI as CFO in March 2022 having previously been CFO of Clinigen, a UK AIM listed Global Pharmaceutical and Pharma Services company with over £450m of revenue. Prior to this Nick was an equity analyst covering the European healthcare space for over eight years, first at Investec and then at RBC where he was Managing Director and Head of RBC’s European healthcare equity research team. Nick began his career at Lloyd’s Pharmacy, registering as a pharmacist before joining GlaxoSmithKline (‘GSK’) where he completed his accountancy qualification (ACMA) working within GSK’s finance function.